Axsome Therapeutics Inc (AXSM)
87.15
-1.69
(-1.90%)
USD |
NASDAQ |
Nov 04, 16:00
87.16
+0.01
(+0.01%)
After-Hours: 20:00
Axsome Therapeutics Shareholders Equity (Quarterly): 102.85M for June 30, 2024
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2024 | 102.85M |
| March 31, 2024 | 144.04M |
| December 31, 2023 | 190.98M |
| September 30, 2023 | 269.51M |
| June 30, 2023 | 278.80M |
| March 31, 2023 | 111.81M |
| December 31, 2022 | 109.56M |
| September 30, 2022 | 157.36M |
| June 30, 2022 | 15.20M |
| March 31, 2022 | 14.70M |
| December 31, 2021 | 15.63M |
| September 30, 2021 | 42.72M |
| June 30, 2021 | 71.44M |
| March 31, 2021 | 96.29M |
| December 31, 2020 | 113.79M |
| September 30, 2020 | 135.26M |
| June 30, 2020 | 154.24M |
| March 31, 2020 | 156.16M |
| December 31, 2019 | 178.72M |
| Date | Value |
|---|---|
| September 30, 2019 | 6.823M |
| June 30, 2019 | 24.28M |
| March 31, 2019 | 17.37M |
| December 31, 2018 | 0.9379M |
| September 30, 2018 | 0.7428M |
| June 30, 2018 | 7.009M |
| March 31, 2018 | 12.59M |
| December 31, 2017 | 16.72M |
| September 30, 2017 | 16.84M |
| June 30, 2017 | 22.75M |
| March 31, 2017 | 29.28M |
| December 31, 2016 | 21.57M |
| September 30, 2016 | 28.18M |
| June 30, 2016 | 34.90M |
| March 31, 2016 | 41.23M |
| December 31, 2015 | 46.44M |
| September 30, 2015 | 3.904M |
| June 30, 2015 | -7.212M |
| December 31, 2014 | -3.203M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
14.70M
Minimum
Mar 2022
278.80M
Maximum
Jun 2023
124.16M
Average
113.79M
Median
Dec 2020
Shareholders Equity (Quarterly) Benchmarks
| Krystal Biotech Inc | 838.89M |
| Pfizer Inc | 87.70B |
| Sarepta Therapeutics Inc | 1.077B |
| Moderna Inc | 11.71B |
| NovaBay Pharmaceuticals Inc | -0.617M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 548.23M |
| Total Liabilities (Quarterly) | 445.37M |
| Debt to Equity Ratio | 1.744 |
| Current Ratio | 2.482 |
| Net Debt Paydown Yield | -0.16% |